U.S. Consumer Services Stock News

If you are trying to work out whether Lindsay's share price lines up with its underlying value, you are not alone. This article is built to help you unpack that question step by step. Lindsay's shares last closed at US$125.38, with returns of 3.5% year to date and declines of 3.3% over the past week, 6.9% over the past month, 2.8% over the past year, 6.0% over three years and 20.4% over five years. These figures may influence how investors are thinking about both growth potential and...

RTX (RTX) is back in focus after its Raytheon business completed a $115 million, 26,000 square foot expansion of the Redstone Missile Integration Facility, increasing integration and delivery capacity by more than 50%. See our latest analysis for RTX. The latest missile facility expansion comes as RTX shares trade at US$204.52, with a 90 day share price return of 14.47% and a 1 year total shareholder return of 59.99%. This suggests that momentum has been building around the broader defense...

Hewlett Packard Enterprise (NYSE:HPE) is contending with a prolonged global memory shortage that is affecting its server business. The company is responding with agile supply tactics, multiyear supplier agreements, and pricing adjustments to address higher memory costs and limited availability. HPE expects elevated memory prices and supply constraints to persist through 2027, influencing its ability to meet demand and manage margins. For a company like Hewlett Packard Enterprise, servers...

Earlier this week, Celcuity announced that the Journal of Clinical Oncology published Phase 3 VIKTORIA-1 results showing the gedatolisib triplet and doublet regimens substantially reduced the risk of disease progression or death versus fulvestrant alone in HR-positive, HER2-negative PIK3CA wild-type advanced breast cancer after CDK4/6 inhibitor and aromatase inhibitor therapy. The data highlight gedatolisib’s differentiated, multi-target PAM pathway inhibition, which produced a 7.3-month...

Western Midstream Partners (WES) is back in focus after revamping its long term agreement with Occidental, shifting to fixed fees with minimum volume commitments through 2035 and receiving a large share transfer in return. See our latest analysis for Western Midstream Partners. Against that backdrop, Western Midstream Partners' share price is at US$40.82, with a 90 day share price return of 3.58% and a year to date gain of 2.77%. Its 1 year total shareholder return of 9.28% sits on top of...

Earlier this week, Diodes Incorporated expanded its automotive power management lineup by launching the AL8859Q, a multi-phase SPI boost controller designed for advanced, functionally safe headlight and broader vehicle power systems, alongside a standard-compliance AL8859 version for industrial and consumer use. By combining high efficiency, tight voltage accuracy, EMI-friendly spread-spectrum modulation, and extensive diagnostics in a compact package priced at US$0.60 for 10,000-piece...

Why Sonoco Products is on investors’ radar Sonoco Products (SON) has drawn fresh attention after recent share price moves, with the stock closing at $53.32 as investors reassess its long history in packaging across consumer and industrial markets. See our latest analysis for Sonoco Products. The recent 1 day share price return of 1.1% builds on a 25.6% 90 day share price return and a 22.3% 1 year total shareholder return, suggesting momentum has been improving after a quieter multi year...

Trust Platform expansion sharpens focus on security driven demand Microchip Technology (MCHP) has extended its Trust Platform with the TA101 TrustFLEX secure authentication IC and TA101 TrustMANAGER service, targeting tighter cybersecurity rules in industrial and automotive markets. These additions are built for products subject to the EU Cyber Resilience Act and for software defined vehicle architectures, giving manufacturers hardware based authentication, lifecycle key management and...

Government contract wins put Reliance (RS) in focus Reliance (RS) drew investor attention after subsidiary AMI Metals secured two sizeable U.S. government contracts, one tied to border wall steel and logistics and another supporting Lockheed Martin’s F-35 aluminum plate processing. See our latest analysis for Reliance. Despite the AMI Metals contract wins and recent broker commentary, Reliance’s share price has pulled back with a 17.5% 1 month share price return. However, the 1 year total...

Why Fair Isaac is back in focus Fair Isaac (FICO) has jumped back onto investors’ radar after two linked developments, rising pressure from rival credit scores in U.S. mortgages and a fresh US$1b senior notes issuance. Together, these moves have raised questions about how secure FICO’s core Scores business really is and how management is choosing to fund the next phase of the company’s evolution. See our latest analysis for Fair Isaac. FICO’s share price has been under pressure for several...

Fluence Energy (FLNC) is back in focus after a bullish SEIA and Wood Mackenzie report pointed to strong U.S. solar and storage installations, with solar projected to lead new grid capacity additions in 2025. See our latest analysis for Fluence Energy. Fluence Energy’s recent moves reflect a mixed picture, with a 10.83% 7 day share price return and a 26.18% 90 day share price decline, yet a very large 1 year total shareholder return suggests longer term momentum has been stronger than the...

In recent days, Danaher has come under pressure after its US$9.90 billion Masimo acquisition raised questions about higher debt levels, integration risks, and a more cautious full-year 2026 outlook amid sector headwinds. At the same time, a law firm has begun investigating potential fiduciary duty breaches by certain officers and directors, while a Danaher subsidiary, IDBS, received an industry award for biopharma digitalisation in Asia-Pacific. These developments highlight how Danaher’s...

In recent updates, Landstar System expanded its heavy haul and Mexico cross-border services while maintaining dividends, share repurchases, and a lower long-term debt load. This combination of operational expansion and financial conservatism contrasts with softer freight demand and capacity imbalances that have led analysts to trim earnings expectations. Now we’ll explore how analysts’ cautious earnings revisions, despite Landstar’s heavy haul and Mexico expansion, reshape the company’s...

If you are wondering whether BeOne Medicines at around US$284.05 is giving you fair value or a potential mispricing, this article will walk through what the current market price might be saying about the business. The stock has seen mixed returns, with a 5.7% decline over the last 7 days and a 19.1% decline over the last 30 days, set against a 27.2% return over 3 years and 9.6% over 1 year. These figures can change how investors view both its growth prospects and risk. Recent coverage of...

Kadant stock moves: how recent returns stack up for long term holders Kadant (KAI) has seen mixed share performance recently, with a 5.5% decline over the past day and about 9.3% over the past month, while the past 3 months show a 3.9% gain. See our latest analysis for Kadant. Zooming out from the recent pullback, Kadant’s 1-day and 30-day share price returns of 5.5% and 9.3% declines contrast with a 6% year to date gain and a 56.2% three year total shareholder return. This suggests momentum...

Earlier this month, Stewart Information Services’ board declared a first-quarter 2026 cash dividend of US$0.525 per share, while director Bradley C. Allen Jr. purchased 1,000 shares on March 10, 2026, adding to his accumulated insider buying over the past year. Together, the sustained dividend and director share purchase highlight active insider participation and a board signaling confidence in the company’s cash generation and operations. Next, we’ll examine how the reaffirmed dividend...

In recent days, analysts at Canaccord Genuity and Stifel reiterated positive views on Artivion, highlighting the aortic disease pipeline and particularly the NEXUS stent graft system after one-year trial data showed strong sealing and low endoleak rates, with physicians indicating plans to adopt the device if it receives FDA approval. This combination of supportive clinical evidence and physician interest underscores how Artivion’s pipeline products could strengthen its position in treating...

Why laser dicing issues put Enovix (ENVX) in the spotlight Enovix (ENVX) has been drawing attention after several analysts flagged laser dicing problems that are affecting production yields, slowing battery qualification for a key customer and prompting reduced expectations despite continued positive ratings. See our latest analysis for Enovix. Those manufacturing concerns have been reflected in Enovix’s share price, with a 30 day share price return showing a 19.41% decline and a 90 day share...

Alcoa (AA) has moved to sell ten closed industrial sites to data center firms, repurposing idle smelter real estate that sits close to power sources and linking its traditional aluminum business to computing demand. See our latest analysis for Alcoa. Alcoa's stock has seen a sharp shift in sentiment over recent months, with a 37.82% 90 day share price return and a 91.78% 1 year total shareholder return, even after a 3.55% one day pullback to US$63.59, as investors weigh data center land...

Tango Therapeutics (TNGX) is back in focus after reporting fourth quarter and full year 2025 results, outlining a funding runway beyond 2028, and signing a new clinical trial collaboration with Erasca for difficult cancers. See our latest analysis for Tango Therapeutics. The earnings update, extended funding runway and new Erasca collaboration appear to have coincided with building momentum, with the 30 day share price return of 37.19% and year to date share price return of 93.73% sitting...

If you are wondering whether e.l.f. Beauty's share price still reflects its true worth after a strong multi year run, looking closely at its valuation can help put the current price into context. The stock last closed at US$73.41, with returns of an 11% decline over the past 7 days, a 4.4% decline over 30 days, a 5.7% decline year to date, a 7.7% gain over 1 year, 1.3% over 3 years, and a very large gain over 5 years. Recent price moves sit against a backdrop of ongoing interest in e.l.f...

If you are wondering whether Chemed is attractively priced after a tough stretch, this article walks through what the current share price may be implying about its value. The stock closed at US$401.87, with returns of a 1.5% decline over 7 days, 13.2% decline over 30 days, 5.2% decline year to date, 32.5% decline over 1 year, 21.0% decline over 3 years and 9.6% decline over 5 years. This performance may change how investors think about its risk and return trade off. Recent coverage around...

In recent days, Magnolia Oil & Gas reported an 11% increase in proved developed producing reserves, fourth-quarter net income of US$71.4 million, and year-on-year production growth to 103,800 barrels of oil equivalent per day. At the same time, insider share sales and a new 52-week high coincided with analysts highlighting Magnolia’s stronger reserve base and operational efficiency amid shifting geopolitical conditions for oil markets. We’ll now examine how Magnolia’s improved reserves and...

Lazard (LAZ) has been caught in a sector wide selloff, as geopolitical tensions, higher crude prices, and JPMorgan’s lending pullback to private credit providers have fueled liquidity worries and pressured financial stocks. See our latest analysis for Lazard. At a share price of US$40.53, Lazard has seen a 1 day share price return of 0.37% decline, a 7 day share price return of 9.21% decline, and a 30 day share price return of 26.03% decline. Its 1 year total shareholder return of 5.99%...